| Orders | Qty | Bid |
|---|---|---|
| 7 | 116 | 2635.2 |
| 1 | 7 | 2635.1 |
| 1 | 12 | 2634.9 |
| 3 | 20 | 2634.8 |
| 3 | 29 | 2634.7 |
| Ask | Qty | Orders |
|---|---|---|
| 2635.6 | 1 | 1 |
| 2635.9 | 4 | 118 |
| 2636 | 1 | 55 |
| 2636.4 | 2 | 16 |
| 2636.6 | 2 | 41 |

Glenmark Pharmaceuticals Ltd has delivered a return of 14.24% over the last 3 months. The stock was trading at ₹2,317.90 on 21 Aug 2026 and is currently at ₹2,648.00 as of 21 Nov 2026, reflecting a Gain of ₹330.10 per share over this period.
Glenmark Pharmaceuticals Ltd has delivered a 464.30% absolute return over the past 5 years, equivalent to a CAGR of 40.93% per annum. The stock was priced at ₹469.25 in Nov 2021 and has risen to ₹2,648.00 as of 21 Nov 2026. An investment of ₹1,00,000 in Glenmark Pharmaceuticals Ltd five years ago would be worth ₹5,64,300.00 today.
For Q2 FY27, Glenmark Pharmaceuticals Ltd reported: Revenue (Net Sales): ₹24758.20 Cr - Up 1.68% year-on-year from ₹24349.93 Cr in Q1 FY27. Net Income (PAT): ₹4348.94 Cr - Down -40.88% year-on-year from ₹7356.37 Cr in Q1 FY27.
The all-time high (ATH) for Glenmark Pharmaceuticals Ltd was ₹2,677.20, recorded on 11 Nov 2026. At the current price of ₹2,648.00, the stock is trading 1.09% below its all-time high. The all-time low recorded was ₹188.10 on 23 Mar 2020.
Yes,Glenmark Pharmaceuticals Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 15.00 per share between FY2022 and FY2026, with the most recent dividend of ₹2.50 per share for May 26, with an ex-dividend date of 31 Aug 2026. At the current market price of ₹2,648.00, the trailing dividend yield of Glenmark Pharmaceuticals Ltd stands at 7.50%.
Over the last 6 months, Glenmark Pharmaceuticals Ltd has given a return of 10.66%. The stock was priced at ₹2,393.00 on 21 May 2026 and has Rise to ₹2,648.00 as of 21 Nov 2026, a change of ₹255.00 per share.
As of 21 Nov 2026, the share price of Glenmark Pharmaceuticals Ltd is ₹2,648.00 on the NSE and ₹2,648.00 on the BSE. The stock opened at ₹2,607.90, touched a high of ₹2,657.70 and a low of ₹2,601.90 during today's session.
The intraday low for Glenmark Pharmaceuticals Ltd on the NSE today was ₹2,601.90. The stock's 52-week low stands at ₹1,825.10, recorded on 24 Nov 2025. Today's low is 42.56% above the 52-week low, indicating the stock is trading well above its yearly lows.
The intraday high for Glenmark Pharmaceuticals Ltd on the NSE today (21 Nov 2026) was ₹2,657.70. This compares to the 52-week high of ₹2,714.00 recorded on 09 Nov 2026. Today's high was -2.07% below the 52-week high.
Glenmark Pharmaceuticals Ltd has delivered 43.59% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,714.00 on 09 Nov 2026 and a 52-week low of ₹1,825.10 on 24 Nov 2025. It is currently trading at ₹2,648.00 as of 21 Nov 2026.